Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

462 related articles for article (PubMed ID: 33092251)

  • 1. Recycling the Purpose of Old Drugs to Treat Ovarian Cancer.
    Nunes M; Henriques Abreu M; Bartosch C; Ricardo S
    Int J Mol Sci; 2020 Oct; 21(20):. PubMed ID: 33092251
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Current state and outlook for drug repositioning anticipated in the field of ovarian cancer.
    Kobayashi Y; Banno K; Kunitomi H; Tominaga E; Aoki D
    J Gynecol Oncol; 2019 Jan; 30(1):e10. PubMed ID: 30479094
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Use of "Repurposed" Drugs in the Treatment of Epithelial Ovarian Cancer: A Systematic Review.
    Goenka L; Dubashi B; Selvarajan S; Ganesan P
    Am J Clin Oncol; 2022 Apr; 45(4):168-174. PubMed ID: 35320817
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The potential to treat lung cancer via inhalation of repurposed drugs.
    Lee WH; Loo CY; Ghadiri M; Leong CR; Young PM; Traini D
    Adv Drug Deliv Rev; 2018 Aug; 133():107-130. PubMed ID: 30189271
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Old wine in new bottles: Drug repurposing in oncology.
    Antoszczak M; Markowska A; Markowska J; Huczyński A
    Eur J Pharmacol; 2020 Jan; 866():172784. PubMed ID: 31730760
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Drug Repositioning for Ovarian Cancer Treatment: An Update.
    Cavalluzzi MM; Viale M; Rotondo NP; Ferraro V; Lentini G
    Anticancer Agents Med Chem; 2024; 24(8):637-647. PubMed ID: 38367265
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Enhancing Immunotherapy in Ovarian Cancer: The Emerging Role of Metformin and Statins.
    Almeida-Nunes DL; Silvestre R; Dinis-Oliveira RJ; Ricardo S
    Int J Mol Sci; 2023 Dec; 25(1):. PubMed ID: 38203494
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Statins as Potential Chemoprevention or Therapeutic Agents in Cancer: a Model for Evaluating Repurposed Drugs.
    Joharatnam-Hogan N; Alexandre L; Yarmolinsky J; Lake B; Capps N; Martin RM; Ring A; Cafferty F; Langley RE
    Curr Oncol Rep; 2021 Feb; 23(3):29. PubMed ID: 33582975
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Statins as adjuvants in the treatment of ovarian cancer: Controversy and misunderstanding.
    Manzano-León N; Garcia-Lopez P
    Eur J Pharmacol; 2021 Apr; 896():173915. PubMed ID: 33513335
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Role of Common Pharmaceutical Agents on the Prevention and Treatment of Pancreatic Cancer.
    Amin S; Boffetta P; Lucas AL
    Gut Liver; 2016 Sep; 10(5):665-71. PubMed ID: 27563018
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Common medications and survival in women with ovarian cancer: A systematic review and meta-analysis.
    Majidi A; Na R; Dixon-Suen S; Jordan SJ; Webb PM
    Gynecol Oncol; 2020 Jun; 157(3):678-685. PubMed ID: 32317171
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Chemoresistance in ovarian cancer: exploiting cancer stem cell metabolism.
    Li SS; Ma J; Wong AST
    J Gynecol Oncol; 2018 Mar; 29(2):e32. PubMed ID: 29468856
    [TBL] [Abstract][Full Text] [Related]  

  • 13. An Insight into Drug Repositioning for the Development of Novel Anti-Cancer Drugs.
    Bhattarai D; Singh S; Jang Y; Hyeon Han S; Lee K; Choi Y
    Curr Top Med Chem; 2016; 16(19):2156-68. PubMed ID: 26881715
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Beyond aspirin-cancer prevention with statins, metformin and bisphosphonates.
    Gronich N; Rennert G
    Nat Rev Clin Oncol; 2013 Nov; 10(11):625-42. PubMed ID: 24080598
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Repurposing of drugs approved for cardiovascular diseases: Opportunity or mirage?
    Gelosa P; Castiglioni L; Camera M; Sironi L
    Biochem Pharmacol; 2020 Jul; 177():113895. PubMed ID: 32145263
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Repurposed Drugs Trials for Ovarian Cancer.
    DiFeo A
    Cancer J; 2019; 25(2):149-152. PubMed ID: 30896539
    [No Abstract]   [Full Text] [Related]  

  • 17. Screening a library of approved drugs reveals that prednisolone synergizes with pitavastatin to induce ovarian cancer cell death.
    Abdullah MI; Abed MN; Khanim F; Richardson A
    Sci Rep; 2019 Jul; 9(1):9632. PubMed ID: 31270377
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Therapeutic options following second-line platinum-based chemotherapy in patients with recurrent ovarian cancer: Comparison of active surveillance and maintenance treatment.
    Ray-Coquard I; Mirza MR; Pignata S; Walther A; Romero I; du Bois A
    Cancer Treat Rev; 2020 Nov; 90():102107. PubMed ID: 33099187
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Using a novel computational drug-repositioning approach (DrugPredict) to rapidly identify potent drug candidates for cancer treatment.
    Nagaraj AB; Wang QQ; Joseph P; Zheng C; Chen Y; Kovalenko O; Singh S; Armstrong A; Resnick K; Zanotti K; Waggoner S; Xu R; DiFeo A
    Oncogene; 2018 Jan; 37(3):403-414. PubMed ID: 28967908
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Is antidyslipidemic statin use for cancer prevention a promising drug repositioning approach?
    Kobayashi Y; Banno K; Kunitomi H; Nagai S; Takahashi T; Anko M; Iijima M; Takeda T; Matoba Y; Nakamura K; Tsuji K; Tominaga E; Aoki D
    Eur J Cancer Prev; 2019 Nov; 28(6):562-567. PubMed ID: 30418231
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.